Merck KGaA

In News

Does Merck KGaA’s Rebound Reflect Its True Value After AI Partnership And CEO Change News - Yahoo Finance

Yahoo Finance - Dec 18, 2025

Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal - Reuters

Reuters - Nov 20, 2025

Immunome’s rare tumor drug passes Phase 3 test, could challenge Merck KGaA - Endpoints News

Endpoints News - Dec 15, 2025

Is Merck KGaA Offering an Opportunity After Recent Share Price Rebound? - simplywall.st

simplywall.st - Dec 18, 2025

The 'Knockout' Hit That Sent This Top 3% Biotech Stock Flying - Investor's Business Daily

Investor's Business Daily - Dec 15, 2025

Merck KGaA given FDA Fast Track designation for generalised myasthenia gravis drug - PMLiVE

PMLiVE - Nov 25, 2025

Merck KGaA (OTCMKTS:MKKGY) Shares Gap Up - What's Next? - MarketBeat

MarketBeat - Dec 16, 2025

Merck KGaA ventures into new territory in the US - Pharma Voice

Pharma Voice - Aug 15, 2025

Merck target raised after analyst change - marketscreener.com

marketscreener.com - Dec 19, 2025

Merck KGaA links up with Flagship's Valo Health in search for Parkinson's targets, offers $3B in biobucks - Fierce Biotech

Fierce Biotech - Nov 20, 2025

Merck KGaA eyes new Parkinson’s disease assets with $3bn Valo partnership - Pharmaceutical Technology

Pharmaceutical Technology - Nov 20, 2025

Merck KGaA's EMD Serono strikes MFN deal in Trump's fertility treatment pricing push - Fierce Pharma

Fierce Pharma - Oct 17, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment